What is AMD?

Vinaora Nivo Slider 3.x
Age-related Macular Degeneration (AMD)

 

Age-related Macular Degeneration (AMD)

The macula is the part of the eye responsible for your central vision, which is used for reading,
driving and performing other activities that require fine, sharp or straight-ahead vision1


 

There are two types of AMD - DRY and WET

  • DRY AMD - the most common form, affecting approximately 90% of people who have the disease WET AMD - this type of AMD affects only about 10% of people with the disease, but it is responsible for 90% of severe vision loss1

Who experiences AMD:

  • Occurs naturally as we age - AMD is the leading cause of irreversible central blindness in people 65 years of age and older1-3
  • Hereditary1-3

Modifiable lifestyle risk factors include:

  • Exposure to excessive sunlight, Obesity, High blood pressure, Smoking, Diet, Alcohol, Light eye / skin colour (non-modifiable)1-3

Symptoms of DRY AMD1,4:

  • Blurred vision and cloudy areas of central vision
  • Dark spots in front of the eyes
  • Reduced sensitivity to contrast
  • Difficulty adjusting from bright to dim lighting
  • Difficulty reading small print
  • There is no pain associated with either form of AMD

Symptoms of WET AMD1,4:

  • Large dark spots in or around the central vision
  • Rapid or sudden visual loss over days or weeks
  • Blindness

Causes of DRY AMD:

  • Drusen (yellow deposits) accumulation under the retina, as AMD progresses, drusen impair the ability of vision cells to transport vital nutrients to the macula, which lead to noticeable symptoms5

Causes of WET AMD:

  • Abnormal blood vessels behind the macular start to grow under the retina, pushing the macular up from its normal position to leak, bleed and scar, resulting in rapid central vision loss5

What to do:


References: 1. Age-related Macular Degeneration (ARMD) symptoms and treatment. Available at: http://www.patient.co.uk/health/age-relatedmaculardegeneration-leafl et http://www.patient.co.uk/pdf/4860.pdf. [Accessed February 6, 2014]. 2. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257–293. 3. Coleman HR, et al. Age-related macular degeneration. Lancet. 2008 Nov 22;372(9652):1835-45. 4. Porter RS, editor. The Merck Manual Home Health Handbook. New Jersey, John Wiley & Sons, Inc.,2009; 907,924,1412-1414, 1453-1454. 5. Facts About Age-Related Macular Degeneration (NEI Health Information).[Cited 2014 May 12]; Available from URL: http://www.nei.nih.gov/health/maculardegen/armd_facts.asp. 6. Rasmussen HM, et al. Nutrients for the aging eye. Clinical Interventions in Aging 2013; 8:741–748. 7. Chew EY on behalf of the The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial. JAMA 2013; 309(19):2005-2015.

 

Ophthalmologists’ No.1 prescribed Eye Health Supplement1

How Ocuvite Complete may help reduce the risk of AMD?

Vitamin and mineral supplementation may reduce the risk of progression of moderate to advanced AMD2-3
 

Nutrients

Per 2 capsules

May assist in inhibiting Pro-inflammatory mediators and promote a healthy ocular surface4,5

Fish oil

1015,4 mg

with Omega-3 fatty acids

600 mg

of which DHA

360 mg

Forms the protective macular pigment that may help filter harmful blue light2

Lutein

10 mg

Zeaxanthin

2 mg

Antioxidants may help neutralize excess free radicals2

Vitamin E

30 mg

Vitamin C

180 mg

Zinc

15 mg

Suitable for

  • AMD
  • Dry Eye symptoms6
  • Smokers

Recommended dosage

2 capsules daily with a meal

Food supplements should not be used as a substitute for a well-balanced, varied diet and a healthy life style.

References: 1. Impact Rx. Script data – May 2015. 2. Rasmussen HM, et al. Nutrients for the aging eye. Clinical Interventions in Aging 2013; 8:741–748. 3. Chew EY on behalf of the The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial. JAMA 2013; 309(19):2005-2015. 4. Mertzanis P, et al. The relative burden of dry eye in patients’ lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci. 2005 Jan;46(1):46-50. 5. Omega-3 Fatty Acids. Available at: http://umm.edu/health/medical/altmed/supplement/omega3-fatty-acids. [Accessed May 26, 2014]. 6. Graham, RH. There’s nothing fi shy about omega-3 fatty acids for dry eye syndrome. Medscape Ophthalmology. Available at http://www.medscape.com/viewarticle/707984_2. [Accessed January 13,2014]. Applicant: iNova Pharmaceuticals (Pty) Ltd. Reg. No.: 1952/001640/07.


 

South Africa’s leading Eye Health Supplement Brand1

 

How Ocuvite Lutein may help reduce the risk of AMD?

Vitamin and mineral supplementation may reduce the risk of progression of moderate to advanced AMD2,3

 

Nutrients

Per 2 tablets

Forms the protective macular pigment that may help filter harmful blue light2

Lutein

6 mg

Zeaxanthin

0,5 mg

Antioxidants may help neutralize excess free radicals2

Vitamin E

8,8 mg

Vitamin C

60 mg

Zinc

5 mg

Selenium

20 μg

Suitable for

  • AMD
  • Smokers

Recommended dosage

2 tablets daily with a meal

Food supplements should not be used as a substitute for a well-balanced, varied diet and a healthy life style.

References: 1.Impact Rx. Script data – May 2015. 2. Rasmussen HM, et al. Nutrients for the aging eye. Clinical Interventions in Aging 2013; 8:741–748. 3. Chew EY on behalf of the The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial. JAMA 2013; 309(19):2005-2015. Applicant: iNova Pharmaceuticals (Pty) Ltd. Reg. No.: 1952/001640/07.

 

 

Marieke van Nieuwkerk
Brand Manager
087 820 7002
m.vannieuwkerk@bausch.co.za

 

 

Bronwen Coleman
Marketing Manager
087 820 7002
b.coleman@bausch.co.za

 

 

Claudia Marais
National Sales Manager Surgical
087 820 7002
c.marais@bausch.co.za

 

 

Marianne Oosthuizen
Responsible Pharmacist
087 820 7002
m.oosthuizen@bausch.co.za

 

Get in Touch

Address:15E Riley Road, Bed­ford­view, 2008,
Johan­nes­burg, South Africa
Tele­phone:+27 11 087 0000 / 087 820 7002
Email: m.vannieuwkerk@bausch.co.za

Our Loca­tion

BlankMap World